HLA-B*07:02 protein (SBP Tag)
Kurzübersicht für HLA-B*07:02 protein (SBP Tag) (ABIN7273184)
Target
Protein-Typ
Spezies
Quelle
Applikation
Reinheit
-
-
Aufreinigungstag / Konjugat
- SBP Tag
-
Verwendungszweck
- The product is HLA-B*07:02 complexed with β2-microglobulin (b2m)
-
Sequenz
- heavy chain: GSHSMRYFYT SVSRPGRGEP RFISVGYVDD TQFVRFDSDA ASPREEPRAP WIEQEGPEYW DRNTQIYKAQ AQTDRESLRN LRGYYNQSEA GSHTLQSMYG CDVGPDGRLL RGHDQYAYDG KDYIALNEDL RSWTAADTAA QITQRKWEAA REAEQRRAYL EGECVEWLRR YLENGKDKLE RADPPKTHVT HHPISDHEAT LRCWALGFYP AEITLTWQRD GEDQTQDTEL VETRPAGDRT FQKWAAVVVP SGEEQRYTCH VQHEGLPKPL TLRWEPSSQS TVPI light chain: IQRTPKIQVY SRHPAENGKS NFLNCYVSGF HPSDIEVDLL KNGERIEKVE HSDLSFSKDW SFYLLYYTEF TPTEKDEYAC RVNHVTLSQP KIVKWDRDM Sequences without tags. Tag location is at the discretion of the manufactur er. If you have a special request, please contact us.
-
Spezifität
-
HLA-B*07:02 complexed with b2m, P01889 / P61769
HLA-B*07:02 presents peptides with the common motif of a proline residue at position 2 and a leucine residue at the c-terminal position 9, e.g. self-peptides derived from signal sequences or viral peptides derived from HIV or SARS-CoV-2. -
Produktmerkmale
-
HLAs are produced in mammalian cell cultures as recombinant, truncated, soluble antigens, in complex with β2-microglobulin (HLA class I). As part of our quality control, all HLA are analyzed for purity by gel electrophoresis, concentration is determined by ELISA (0.5 mg/mL) and their functionality is verified with a specific antiserum.
contains endogenous peptides. -
Aufreinigung
- Chromatography
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
- ELISA: 1 - 100 ng/mL
-
Kommentare
-
reactive with antibodies W6,32,BBM.1,specific antiserum, B cell ELI Spot (predicted), in vitro memory B cell stimulation (predicted), HLA competition assay (predicted), control in various assays (predicted)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- TRIS based buffer, pH 8.0, Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Shelf life: 6 month from date of production. Store at 2 °C - 8 °C
-
Haltbarkeit
- 6 months
-
-
- HLA-B*07:02
-
Hintergrund
- Human Leukozyte Antigen, human Antigen-presenting major histocompatibility complex class I (MHCI) molecule. Expressed on all cells, displays peptides to CD8-positive T cells. Involved in cellular immune response.
-
Molekulargewicht
- approx. 50 kDa (38 kDa heavy chain + 12 kDa b2m)
-
UniProt
- P01889
Target
-